Similar articles

• [Clinical evaluation of CA 19-9, TPA, IAP and 5'-NPD-V as tumor markers of hepatocellular, bile duct and pancreas carcinoma].

  Takahashi H, Miyazaki H, Deura M, Shimizu Y, Asukata I, Kameda H. Takahashi H, et al. Gan No Rinsho. 1985 May;31(6 Suppl):623-30. Gan No Rinsho. 1985. PMID: 2411964 Japanese.
• Useful blood tests in the diagnosis and management of cancer: a review. Part III Antigens and Antibodies.

  Hartman HA Jr, Foley JF. Hartman HA Jr, et al. Nebr Med J. 1977 Jun;62(6):184-9. Nebr Med J. 1977. PMID: 69997 Review. No abstract available.
• [An overview of tumor markers].

  Morita R, Fukunaga M, Ohtsuka N. Morita R, et al. Rinsho Hoshasen. 1986 Jan;31(1):1-10. Rinsho Hoshasen. 1986. PMID: 2422414 Review. Japanese. No abstract available.
• Tumor associated markers in clinical diagnosis.

  Rochman H. Rochman H. Ann Clin Lab Sci. 1978 May-Jun;8(3):167-75. Ann Clin Lab Sci. 1978. PMID: 77652 Review. No abstract available.
• [Tumor markers for hepatoma and carcinoma of biliary tract].

  Higashino K. Higashino K. Rinsho Byori. 1985 Aug;33(8):861-71. Rinsho Byori. 1985. PMID: 2416966 Review. Japanese. No abstract available.